Overview
Headquarters
Fort Collins, Co
Zila is a fully integrated, oral hygiene company dedicated to oral health and soft tissue management. Zila designs, manufactures and markets a portfolio of products sold exclusively to dental professionals. All Zila products are proudly made in the U.S.A. Zila, Inc. is a specialty pharmaceutical company dedicated to the prevention, detection and treatment of oral diseases, with a primary focus on oral cancer. The Company's products helps with the early detection oral abnormalities that could lead to cancer. Zila designs, manufactures and markets a suite of proprietary product sold exclusively and directly to dental professionals. Zila is developing and commercializing oral cancer detection technology, as well as equipment used to prevent and treat periodontal disease. Its lead cancer diagnostic product is the ViziLite Plus test kit, which uses a chemiluminescent light source to detect cancerous oral lesions. Despite its FDA approval as an adjunctive diagnostic (to be used along with other methods), the ViziLite has yet to fully take off in the US. Other products include the periodontal scalers, probes, fluoride rinses, and cleaning equipment for office and home use. After experiencing financial difficulties, Zila was acquired by private drugmaker TOLMAR Holding in 2009. Zila is developing and commercializing oral cancer detection technology, as well as equipment used to prevent and treat periodontal disease. Its lead cancer diagnostic product is the ViziLite Plus test kit, which uses a chemiluminescent light source to detect cancerous oral lesions. Despite its FDA approval as an adjunctive diagnostic (to be used along with other methods), the ViziLite has yet to fully take off in the US. Other products include the periodontal scalers, probes, fluoride rinses, and cleaning equipment for office and home use. After experiencing financial difficulties, Zila was acquired by private drugmaker TOLMAR Holding in 2009. Try D&B Hoovers Free Zila is developing and commercializing oral cancer detection technology, as well as equipment used to prevent and treat periodontal disease. Its lead cancer diagnostic product is the ViziLite Plus test kit, which uses a chemiluminescent light source to detect cancerous oral lesions. Despite its FDA approval as an adjunctive diagnostic (to be used along with other methods), the ViziLite has yet to fully take off in the US. Other products include the periodontal scalers, probes, fluoride rinses, and cleaning equipment for office and home use. After experiencing financial difficulties, Zila was acquired by private drugmaker TOLMAR Holding in 2009.
